Australian (ASX) Stock Market Forum

ACL - Australian Clinical Labs (1 Viewer)

System

Administrator
Joined
Jun 27, 2010
Posts
3,273
Reactions
91
Australian Clinical Labs is a leading private provider of pathology services in Australia. ACL annually collects, analyses and reports on 8.3 million episodes via its national network of 995 collection centres, 30 clinics and 86 accredited laboratories.

ACL is one of the largest private pathology providers to hospitals nationally, servicing over 90 private and public hospitals. In its four established regions of Western Australia, Victoria, South Australia and the Northern Territory, ACL has an equivalent market position in community pathology to Sonic Healthcare and Healius. ACL also has a growing presence in New South Wales and the Australian Capital Territory and has recently expanded into Queensland.

ACL had pro forma revenues of $595.1 million and pro forma EBITDA of $178.6 million for the 12 months to 31 December 2020.

It is anticipated that ACL will list on the ASX during May 2021.

 

Dona Ferentes

Cacoëthes blogendi
Joined
Jan 11, 2016
Posts
4,018
Reactions
4,123
Listing date14 May 2021 12:00 PM ##
Contact details (03) 9538 6777
Principal ActivitiesProvision of pathology services
GICS industry groupTBA
Issue Price$4.00
Issue TypeOrdinary Fully Paid Shares
Security codeACL
Capital to be Raised$408,600,000
Expected offer close date12 May 2021
UnderwriterThis offer is fully underwritten. Merrill Lynch Equities (Australia) Limited and Goldman Sachs Australia Pty Ltd (Joint Lead Manager)
 

Dona Ferentes

Cacoëthes blogendi
Joined
Jan 11, 2016
Posts
4,018
Reactions
4,123
another overpriced IPO?

Priced at 4.00, opened on Friday 14 May at $3.80 and a steady decline most of the trading day, to close at $3.42
 

Users who are viewing this thread

Top